Buffalo, NY, December 5th, 2018 - PostProcess Technologies (PPT) announced today a partnership with CUBRC, a leader in machine learning research, development, testing and systems integration, to leverage their cutting-edge Heartwood Analytics™ suite for PPT’s next-generation software platforms. As the pioneer of software-based 3D post-printing solutions driving automation for the third stage of Additive Manufacturing (AM), the partnership with CUBRC significantly advances PPT’s work on the full digitization of AM through the post-print step for the Industry 4.0 factory floor.Read more ...
Buffalo, NY – October 2, 2018 – CUBRC, Inc.’s President and CEO, Tom McMahon, announced today that CUBRC, in collaboration with EpiVax, Inc., was awarded a two-year contract worth $1.0 million from the Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS). The new program is relevant to the new draft guidance issued by the Office on Generic Drugs (OGD) highlighting the use of in silico analysis in accelerated new drug applications for generic peptide drugs [for additional info see link to FDA guidance here: FDA].Read more ...
Buffalo, NY–February 23, 2018
CUBRC Inc., a leading Research, Development, Testing and Systems Integration company, has been awarded a three-year, $4.1M contract from the Defense Threat Reduction Agency (DTRA) entitled, Computational Assessment of Compound Toxicity. The overall objective of this contract is to intelligently link chemical structure, physicochemical properties, biochemical properties and biological activity from multiple databases, assays, models and tools to provide accurate predictions of acute, debilitating chemical toxicity with enough confidence to alert of potential threats and to guide subsequent toxicity characterization efforts.Read More
The University at Buffalo and the Chicago-based Digital Manufacturing and Design Innovation Institute (DMDII) have entered into an agreement to implement a $1.3 million project designed to create and test work flow innovations using a standard vocabulary and set of categories, forming what can be called a suite of ontologies, to support digital manufacturing for a local technology and services innovator.Read More
CUBRC, Inc.’s President and CEO, Tom McMahon, announced today that CUBRC’s Biological and Medical Sciences team, in collaboration with EpiVax, Inc., has received a four-year grant worth $1.87 million from the Defense Threat Reduction Agency (DTRA) within the Department of Defense (DoD).Read More